Post-Brexit plans to relocate the European Medicines Agency could trigger severe staff losses, its head has warned.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 52 print issues and online access
$199.00 per year
only $3.83 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Vesper, I. European drug regulation at risk of stalling as agency prepares to leave London. Nature (2017). https://doi.org/10.1038/nature.2017.22817
Published:
DOI: https://doi.org/10.1038/nature.2017.22817
